ARCHIVES

NCI Considering Combining Support, Control Core Grants; Directors Reject Two Grants, One Review

This article is from The Cancer Letter archive.

Vol. 04 No. 22 | June 2, 1978

Download PDF Visit The Full Archive

Related Articles

In Brief: Marks’ Appointment As President, Chief Executive Officer Of Memorial Sloan-Kettering, Official

June 27, 1980

NCI-Approved Clinical Trials

July 30, 2004

Radiation Therapy Combination Better For Treating Cancer Spread To Brain

May 28, 2004

New NIH Chief Splits with Predecessors, HEW Brass, Opposes “Balance,” Likes Cancer Program

October 24, 1975

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

December 26, 2014

Zevalin Regimen Better Than Rituximab Alone For NHL

June 29, 2001